Triple
T11698259
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CB2 receptor |
E278052
|
entity |
| Predicate | hasAlternativeName |
P39
|
FINISHED |
| Object | cannabinoid receptor type 2 |
E278052
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: cannabinoid receptor type 2 | Statement: [CB2 receptor, hasAlternativeName, cannabinoid receptor type 2]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: cannabinoid receptor type 2 Context triple: [CB2 receptor, hasAlternativeName, cannabinoid receptor type 2]
-
A.
CB2 receptor
chosen
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
B.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
C.
endocannabinoid system
The endocannabinoid system is a widespread cell-signaling network in the body that helps regulate processes such as mood, appetite, pain, memory, and immune function through cannabinoid receptors, endogenous ligands, and metabolic enzymes.
-
D.
rimonabant
Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
-
E.
constitutive androstane receptor
The constitutive androstane receptor (CAR) is a nuclear receptor that senses xenobiotics and endogenous compounds to regulate the expression of drug-metabolizing enzymes and transporters in the liver.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aafe02d881909900d54ad7d4af84 |
completed | April 8, 2026, 7:22 p.m. |
| NER | Named-entity recognition | batch_69d8a47df68c81908a91919a69b4880d |
completed | April 10, 2026, 7:19 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ef147e2e10819085eaed83fd955b6b |
completed | April 27, 2026, 7:47 a.m. |
Created at: April 8, 2026, 9:40 p.m.